inhibitor

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Audio19:20Notes
   +Listen later
2. 2▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Video19:20Notes
   +Watch later
3. 3▶Rethinking Breast Cancer ScreeningOncTimes Talk35:15Notes
   +Listen later
4. 4▶Entelo Bio CEO, Peter Crane, on preserving human resilienceBreakthroughNotes
   +Listen later
5. 5▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Audio26:33Notes
   +Listen later
6. 6▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Video26:33Notes
   +Watch later
7. 7▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Immunology & Infectious Disease Audio20:43Notes
   +Listen later
8. 8▶Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Audio20:17Notes
   +Listen later
9. 9▶Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Audio29:54Notes
   +Listen later
10. 10▶Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Video20:17Notes
    +Watch later
11. 11▶Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Video29:54Notes
    +Watch later
12. 12▶Inside Lytix Biopharma's Breakthrough in ImmunotherapyOncTimes Talk22:57Notes
    +Listen later
13. 13▶A Lap Around the Couch: Why Exercise Matters in Cancer CareOncTimes Talk34:35Notes
    +Listen later
14. 14▶Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Audio1:15:47Notes
    +Listen later
15. 15▶Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Video1:15:47Notes
    +Watch later
16. 16▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Brain & Behaviour Audio36:53Notes
    +Listen later
17. 17▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Brain & Behaviour Video36:53Notes
    +Watch later
18. 18▶Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age SpectrumPeerVoice Brain & Behaviour Audio27:58Notes
    +Listen later
19. 19▶Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age SpectrumPeerVoice Brain & Behaviour Video27:58Notes
    +Watch later
20. 20▶Understanding the Rise in Early-Onset CancerOncTimes Talk34:12Notes
    +Listen later
21. 21▶My IQWiG lecture in Cologne! What a great audience and team!The Oncology Shot with Timothee OlivierNotes
    +Listen later
22. 22▶Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Audio1:10:40Notes
    +Listen later
23. 23▶Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Video1:10:40Notes
    +Watch later
24. 24▶Championing Community Cancer CareOncTimes Talk27:59Notes
    +Listen later
25. 25▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Immunology & Infectious Disease Audio21:52Notes
    +Listen later
26. 26▶Yohei Doi, MD, PhD - Know the Risk, Act on Evidence: Strategic Interventions in COVID-19 Care of High-Risk PatientsPeerVoice Immunology & Infectious Disease Audio28:36Notes
    +Listen later
27. 27▶Radioactive Resilience: A Survivor's Mission to Cure CancerOncTimes Talk19:08Notes
    +Listen later
28. 28▶Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?PeerVoice Brain & Behaviour Audio16:18Notes
    +Listen later
29. 29▶Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?PeerVoice Brain & Behaviour Video17:00Notes
    +Watch later
30. 30▶Results from OncoExTra® Testing of 10K Tumor Samples Show the Next Generation of SequencingOncTimes Talk12:51Notes
    +Listen later
31. 31▶The Evolving Landscape of Bladder CancerOncTimes Talk13:51Notes
    +Listen later
32. 32▶Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health ImpactPeerVoice Immunology & Infectious Disease Audio17:26Notes
    +Listen later
33. 33▶Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health ImpactPeerVoice Brain & Behaviour Audio17:26Notes
    +Listen later
34. 34▶Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health ImpactPeerVoice Brain & Behaviour Video17:26Notes
    +Watch later
35. 35▶The Current State of Skin Cancer in the U.S.OncTimes Talk35:32Notes
    +Listen later
36. 36▶David Alain Wohl, MD - Inpatient Management of SARS-CoV-2 Infection: Applying Learnings From Real World Evidence to Real World PracticePeerVoice Immunology & Infectious Disease Audio38:52Notes
    +Listen later
37. 37▶Nancy Carteron, MD, FACR - Congress Insights Direct From Chicago: The Need-to-Knows on B Cell–Targeting in Sjögren’s DiseasePeerVoice Immunology & Infectious Disease Audio19:49Notes
    +Listen later
38. 38▶United Theranostics and the Future of Cancer CareOncTimes Talk1:09:12Notes
    +Listen later
39. 39▶Eva Diehl - Wiesenecker, MD - Rare Causes of Abdominal Pain: Differential Diagnosis of Uncommon but Diagnosable Causes in the Emergency RoomPeerVoice Immunology & Infectious Disease Audio18:36Notes
    +Listen later
40. 40▶Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic MastocytosisPeerVoice Immunology & Infectious Disease Audio15:54Notes
    +Listen later
41. 41▶Martin Metz, MD - Bringing Chronic Spontaneous Urticaria Under Control: Available and Anticipated Strategies for Escalating TreatmentPeerVoice Immunology & Infectious Disease Audio19:27Notes
    +Listen later
42. 42▶Howard Trachtman, MD - Pioneering Progress In Focal Segmental Glomerulosclerosis: Time is Ticking To Save The NephronPeerVoice Immunology & Infectious Disease Audio20:38Notes
    +Listen later